ID: ALA295629

Max Phase: Preclinical

Molecular Formula: C12H16O8

Molecular Weight: 288.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=C(OC)C(C(COC(C)=O)OC(C)=O)OC1=O

Standard InChI:  InChI=1S/C12H16O8/c1-6(13)18-5-8(19-7(2)14)9-10(16-3)11(17-4)12(15)20-9/h8-9H,5H2,1-4H3

Standard InChI Key:  XJBVOZILOBKRIF-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 288.25Molecular Weight (Monoisotopic): 288.0845AlogP: -0.09#Rotatable Bonds: 6
Polar Surface Area: 97.36Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.52CX Basic pKa: CX LogP: -0.81CX LogD: -0.81
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.49Np Likeness Score: 1.70

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source